Bacopaside II | CAS:382146-66-9 | Manufacturer ChemFaces

Bacopaside II

ChemFaces products have been cited in many studies from excellent and top scientific journals

Order & Inquiry & Tech Support

Tel: (0086)-27-84237683
Tech: service@chemfaces.com
Order: manager@chemfaces.com
Address: 176, CheCheng Eest Rd., WETDZ, Wuhan, Hubei 430056, PRC

How to Order

Orders via your E-mail:

1. Product number / Name / CAS No.
2. Delivery address
3. Ordering/billing address
4. Contact information
Order: manager@chemfaces.com

Delivery time

Delivery & Payment method

1. Usually delivery time: Next day delivery by 9:00 a.m. Order now

2. We accept: Wire transfer & Credit card & Paypal

Citing Use of our Products

More Impact Factor than five Cite...

* Packaging according to customer requirements(5mg, 10mg, 20mg and more). We shipped via FedEx, DHL, UPS, EMS and others courier.

According to end customer requirements, ChemFaces provide solvent format. This solvent format of product intended use: Signaling Inhibitors, Biological activities or Pharmacological activities.

Size /Price /Stock	10 mM * 1 mL in DMSO / $218 / In-stock
Other Packaging	*Packaging according to customer requirements(100uL/well, 200uL/well and more), and Container use Storage Tube With Screw Cap

Featured Products

More...

Mulberroside C

Catalog No: CFN99587
CAS No: 102841-43-0
Price: $218/20mg

Ophiopogonin D

Catalog No: CFN98156
CAS No: 41753-55-3
Price: $248/20mg

Protopine

Catalog No: CFN99399
CAS No: 130-86-9
Price: $50/20mg

Candicine

Catalog No: CFN91816
CAS No: 6656-13-9
Price: $ / mg

2-Hydroxycinnamic acid

Catalog No: CFN98193
CAS No: 614-60-8
Price: $30/20mg

Tricin

Catalog No: CFN98841
CAS No: 520-32-1
Price: $258/10mg

Verbasoside

Catalog No: CFN95015
CAS No: 61548-34-3
Price: $318/5mg

6,8-Diprenylgenistein

Catalog No: CFN97935
CAS No: 51225-28-6
Price: $ / mg

Pinocembrin chalcone

Catalog No: CFN96919
CAS No: 4197-97-1
Price: $/mg

Oxymatrine

Catalog No: CFN99805
CAS No: 16837-52-8
Price: $40/20mg

Description:

Bacopaside II is a potential anti-angiogenic agent, it can reduce endothelial cell migration and tubulogenesis and induce apoptosis. Bacopaside II shows antioxidant and antidepressant activities, it can inhibit both basal activity as well as verapamil-stimulated ATPase activity, suggesting its affinity towards P-gp.

Targets:

P-gp | ATPase

In vitro:

Int J Mol Sci. 2018 Feb 26;19(3). pii: E653.

The Aquaporin 1 Inhibitor Bacopaside II Reduces Endothelial Cell Migration and Tubulogenesis and Induces Apoptosis.[Pubmed: 29495367]

Expression of aquaporin-1 (AQP1) in endothelial cells is critical for their migration and angiogenesis in cancer.
METHODS AND RESULTS:
We tested the AQP1 inhibitor, Bacopaside II, derived from medicinal plant Bacopa monnieri, on endothelial cell migration and tube-formation in vitro using mouse endothelial cell lines (2H11 and 3B11) and human umbilical vein endothelial cells (HUVEC). The effect of Bacopaside II on viability, apoptosis, migration and tubulogenesis was assessed by a proliferation assay, annexin-V/propidium iodide flow cytometry, the scratch wound assay and endothelial tube-formation, respectively. Cell viability was reduced significantly for 2H11 at 15 μM (p = 0.037), 3B11 at 12.5 μM (p = 0.017) and HUVEC at 10 μM (p < 0.0001). At 15 μM, the reduced viability was accompanied by an increase in apoptosis of 38%, 50% and 32% for 2H11, 3B11 and HUVEC, respectively. Bacopaside II at ≥10 μM significantly reduced migration of 2H11 (p = 0.0002) and 3B11 (p = 0.034). HUVECs were most sensitive with a significant reduction at ≥7.5 μM (p = 0.037). Tube-formation was reduced with a 15 μM dose for all cell lines and 10 μM for 3B11 (p < 0.0001).
CONCLUSIONS:
These results suggest that Bacopaside II is a potential anti-angiogenic agent.

In vivo:

Heliyon. 2016 Feb 15;2(2):e00068.

Beneficial effects of Bacopa monnieri extract on opioid induced toxicity.[Pubmed: 27441247]

The present study examined the hepatotoxicity and nephrotoxicity of morphine and illicit street heroin and their amelioration by a standardized methanolic extract of Bacopa monnieri (L.) (mBME) in rats.
METHODS AND RESULTS:
Morphine or street heroin was administered at a dose of 20 mg/kg for 14 and 21 days. mBME (40 mg/kg) or ascorbic acid (50 mg/kg) was administered two hours before morphine or street heroin. High performance liquid chromatography (HPLC) was used for the standardization of bacoside-A major components in mBME. The antioxidant potential of mBME was evaluated by 2,2-diphenyl-1-picrylhydrazyl (DPPH) free radical scavenging assay. Administration of morphine and street heroin resulted in marked elevation of serum alanine aminotransferase (ALT), aspartate aminotransferase (AST) and creatinine. Histopathological changes induced by morphine and street heroin after 14 days were of reversible nature while treatment for 21 days was associated with irreversible changes. Pretreatment with mBME or ascorbic acid restored the elevation of serum ALT, AST and creatinine and protected liver and kidneys from the toxicological influence of morphine and street heroin. HPLC analysis showed that mBME contained bacoside-A major components i.e. bacoside A3 (37.5 μg/mg), Bacopaside II (4.62 μg/mg) and bacopasaponin C (1.91 μg/mg). The EC50 for the DPPH free radical scavenging assay revealed that mBME possessed strong antioxidant potential.
METHODS AND RESULTS:
These results concluded that as compared to morphine, street heroin was associated with severe biochemical and histopathological changes in the liver and kidneys. Bacopa monnieri having strong antioxidant potential may provide a beneficial herbal remedy for the efficient management of opioid related hepatotoxicity and nephrotoxicity.

Bacopaside II Description

Source:	The herbs of Bacopa monnieri
Solvent:	DMSO, Pyridine, Methanol, Ethanol, etc.
Storage:	Providing storage is as stated on the product vial and the vial is kept tightly sealed, the product can be stored for up to 24 months(2-8C). Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20C. Generally, these will be useable for up to two weeks. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour. Need more advice on solubility, usage and handling? Please email to: service@chemfaces.com
After receiving:	The packaging of the product may have turned upside down during transportation, resulting in the natural compounds adhering to the neck or cap of the vial. take the vial out of its packaging and gently shake to let the compounds fall to the bottom of the vial. for liquid products, centrifuge at 200-500 RPM to gather the liquid at the bottom of the vial. try to avoid loss or contamination during handling.

Kinase Assay:

Xenobiotica. 2015;45(8):741-9.

In vitro effects of standardized extract of Bacopa monniera and its five individual active constituents on human P-glycoprotein activity.[Pubmed: 25869246 ]

1. For centuries Bacopa monniera (BM) has been used as an herbal drug for the treatment of various mental ailments. A chemically standardized alcoholic extract of BM is clinically available over the counter herbal remedy for memory enhancement in children and adults. Consumption of herbal preparations has been reported to alter the function of membrane transporters, especially P-glycoprotein (P-gp), ATP-dependent drug efflux transporter responsible for the development of herb-drug interactions.
METHODS AND RESULTS:
2. In the present study, we evaluated the in vitro effect of BM extract and its five individual active constituents (namely, bacopaside I, Bacopaside II and bacopasaponin C, bacoside A and bacoside A3) on P-gp function using luminescent P-gp ATPase assay and Rh123 transport assay across human MDR1 gene transfected LLC-GA5-COL150 cell line. 3. It was observed that BM extract and its five individual constituents inhibited both basal activity as well as verapamil-stimulated ATPase activity, suggesting their affinity towards P-gp. Further, BM and its five active constituents inhibited the rhodamine 123 (Rh123) transport across LLC-GA5-COL150 cell monolayer with Bacopaside II being the most potent inhibitor of P-gp, which decreased P-gp efflux ratio of Rh123 by fourfold in comparison to control. 4.
CONCLUSIONS:
Our finding may prove beneficial in predicting the potential herb-drug interactions of BM on concomitant medication with P-gp substrate drugs in clinical settings.

Animal Research:

J Nat Prod. 2007 Apr;70(4):652-5.

Triterpene saponins from Bacopa monnieri and their antidepressant effects in two mice models.[Pubmed: 17343408 ]

METHODS AND RESULTS:
Three new triterpene glycosides, bacopasides VI-VIII (1-3), together with three known analogues, bacopaside I (4), Bacopaside II (5), and bacopasaponsin C (6), were isolated from the whole plant of Bacopa monnieri.
CONCLUSIONS:
Compounds 4, 5, and 6 showed antidepressant activity when tested on forced swimming and tail suspension in mice, respectively.

Product Name	Bacopaside II
Price:	$288 / 10mg
CAS No.:	382146-66-9
Catalog No.:	CFN93234
Molecular Formula:	C₄₇H₇₆O₁₈
Molecular Weight:	929.10 g/mol
Purity:	>=98%
Type of Compound:	Triterpenoids
Physical Desc.:	Powder
Source:	The herbs of Bacopa monnieri
Solvent:	DMSO, Pyridine, Methanol, Ethanol, etc.
Download:	COA MSDS
Similar structural:	Comparison (Web)
Guestbook:

Size /Price /Stock	10 mM * 100 uL in DMSO / Inquiry / In-stock 10 mM * 1 mL in DMSO / Inquiry / In-stock
Related Libraries	Triterpenoids Compound Library P-gp Inhibitor Library ATPase Inhibitor Library

	1 mg	5 mg	10 mg	20 mg	25 mg
1 mM	1.0763 mL	5.3816 mL	10.7631 mL	21.5262 mL	26.9078 mL
5 mM	0.2153 mL	1.0763 mL	2.1526 mL	4.3052 mL	5.3816 mL
10 mM	0.1076 mL	0.5382 mL	1.0763 mL	2.1526 mL	2.6908 mL
50 mM	0.0215 mL	0.1076 mL	0.2153 mL	0.4305 mL	0.5382 mL
100 mM	0.0108 mL	0.0538 mL	0.1076 mL	0.2153 mL	0.2691 mL

CFN91088	Bacoside A3	157408-08-7	929.11	C₄₇H₇₆O₁₈
CFN91082	Bacopaside X	94443-88-6	899.08	C₄₆H₇₄O₁₇
CFN93076	Bacopaside I	382148-47-2	979.13	C₄₆H₇₄O₂₀S
CFN93234	Bacopaside II	382146-66-9	929.10	C₄₇H₇₆O₁₈
CFN93267	Bacopaside V	620592-16-7	766.96	C₄₁H₆₆O₁₃
CFN91182	Bacopaside IV	155545-03-2	767.0	C₄₁H₆₆O₁₃
CFN91081	Bacopaside N2	871706-75-1	796.99	C₄₂H₆₈O₁₄
CFN91080	Bacoside A	11028-00-5	768.98	C₄₁H₆₈O₁₃
CFN93219	Bacopasaponin C	178064-13-6	899.08	C₄₆H₇₄O₁₇